Breast Cancer Clinical Trial

Melody®, a Lab Developed Test for Breast Cancer for Women With Dense Breast Tissue

Summary

Investigation of Melody®, a lab developed test for breast cancer, as a supplemental tool to current screening recommendations for women with dense breast tissue will explore if Melody®, can be used as a support tool in the breast cancer screening protocol for women with dense breast tissue. Melody® was designed and validated by Namida Lab, Inc., a high complexity Clinical Laboratory Improvement Amendments (CLIA) certified lab.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Categorized as having heterogeneously dense or extremely dense tissue 18 years of age or older Able to understand the informed consent process Willing to comply with all study procedures

Exclusion Criteria:

Have an active eye infection Categorized as having fibro glandular densities or fatty breast tissue Currently diagnosed or are receiving treatment for breast cancer Under 18 years of age

Study is for people with:

Breast Cancer

Estimated Enrollment:

1500

Study ID:

NCT05268224

Recruitment Status:

Recruiting

Sponsor:

Namida Lab

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Namida Lab
Fayetteville Arkansas, 72703, United States More Info
Anna Daily, PhD
Contact
479-334-2828
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

1500

Study ID:

NCT05268224

Recruitment Status:

Recruiting

Sponsor:


Namida Lab

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.